(Q37131930)

18 August 2017

1 reference

title

Painful diabetic neuropathy: treatment and future aspects (English)

1 reference

18 August 2017

1 reference

Dan Ziegler

1

1 reference

18 August 2017

1 May 2008

1 reference

Diabetes - Metabolism: Research and Reviews

18 August 2017

1 reference

18 August 2017

24 Suppl 1

1 reference

18 August 2017

S52-7

1 reference

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

18 August 2017

1 reference

Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology

21 January 2018

1 reference

7 January 2021

Diabetic neuropathies

1 reference

7 January 2021

Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3.

1 reference

7 January 2021

Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4

1 reference

7 January 2021

Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model

1 reference

7 January 2021

Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration

1 reference

7 January 2021

Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes

1 reference

7 January 2021

The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes.

1 reference

7 January 2021

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

1 reference

7 January 2021

A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy

1 reference

7 January 2021

Diabetic somatic neuropathies

1 reference

7 January 2021

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

1 reference

7 January 2021

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion

1 reference

7 January 2021

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis

1 reference

7 January 2021

Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review

1 reference

7 January 2021

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

1 reference

7 January 2021

Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial

1 reference

7 January 2021

C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

1 reference

7 January 2021

Diabetic neuropathies: a statement by the American Diabetes Association

1 reference

7 January 2021

Algorithm for neuropathic pain treatment: an evidence based proposal.

1 reference

7 January 2021

Mechanisms of disease: mechanism-based classification of neuropathic pain-a critical analysis

1 reference

7 January 2021

New perspectives on the management of diabetic peripheral neuropathic pain

1 reference

7 January 2021

Duloxetine vs. placebo in patients with painful diabetic neuropathy

1 reference

7 January 2021

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

1 reference

7 January 2021

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

1 reference

7 January 2021

Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain

1 reference

7 January 2021

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

7 January 2021

Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study

1 reference

7 January 2021

Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials

1 reference

7 January 2021

Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies

1 reference

7 January 2021

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

1 reference

7 January 2021

Morphine, gabapentin, or their combination for neuropathic pain.

1 reference

7 January 2021

Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation

1 reference

7 January 2021

Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy

1 reference

7 January 2021

Reversal of diabetic peripheral neuropathy with phototherapy (MIRE) decreases falls and the fear of falling and improves activities of daily living in seniors.

1 reference

7 January 2021

The effect of monochromatic infrared energy on sensation in patients with diabetic peripheral neuropathy: a double-blind, placebo-controlled study

1 reference

7 January 2021

Emerging drugs in neuropathic pain

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.817

1 reference

18 August 2017

1 reference

PubMed ID

18395890